R. Bastús

Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study

Jorge Aparicio, J.R. Germà, Xavier García del Muro et al. · Journal of Clinical Oncology · 2005 · 231 citations

Medicine, Oncology, Surgery +13

Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium

Joaquim Bellmunt, Vicente Guillém, Luis Paz‐Ares et al. · Journal of Clinical Oncology · 2000 · 191 citations

Medicine, Oncology, Pharmacology +17

Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study

Jorge Aparicio, Pablo Maroto, Xavier García del Muro et al. · Journal of Clinical Oncology · 2011 · 127 citations · Full text

Medicine, Oncology, Surgery +16

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)

Jorge Aparicio, Pablo Maroto, Xavier García del Muro et al. · Annals of Oncology · 2014 · 124 citations · Full text

Medicine, Oncology, Pathology +15

Bladder cancer in the textile industry

Cònsol Serra, Xavier Bonfill, Jordi Sunyer et al. · Scandinavian Journal of Work Environment & Health · 2000 · 29 citations · Full text

Medicine, Oncology, Urology +17